2017년 1월 4일 수요일

Re-Gen Thijs

Re-Gen Thijs

Re-Gen Thijs Co., Ltd.
RegeneTiss Inc.
Kind Company
Market information Non-presentation
The head office location Japanese flag Japan
394-0046
1-4-1, Kawagishinishi, Okaya-shi, Nagano

The establishment I establish it (2004) in January in 2004
Type of industry Manufacturing industry
Business contents

Development and production sale business of the health care products such as an unregulated drug, cosmetics

New pharmaceutical products and medical equipment development business
Representative 代表取締役柴肇一
Capital 46,500,000 yen
The number of employees 18 people
Accounting period December
Outside link Re-Gen Thijs Co., Ltd.
I display a template

Re-Gen Thijs Co., Ltd. (an English company name: regenetiss) is a venture company from the universities developing an unregulated drug establishing the head office in Okaya-shi, Nagano, development and the production sale of the health care products such as cosmetics, new pharmaceutical products and medical equipment.

Table of contents

Summary

柴肇一 (I study in the laboratory of winning Nobel Prize for Medicine [1]) as a postdoctoral fellow in Professor Arthur Kornberg (1959 of the Stanford University medical department biochemistry subject and start for my new post as an assistant professor of Hokkaido University after returning home) of the representative who started the study of the polyphosphoric acid in the Japanese first living body establishes it in January, 2004. The applied technology to a pharmaceutical product of polyphosphoric acid sodium with an anagenesis promotion effect concerned as a nucleus is development by business. I am performed adoption [2] in 2001 by (2001-2003), Ministry of Education, Culture, Sports, Science and Technology original innovation technology development study suggestion open call for participants system (millennium project), and adoption [3] is considered to be it for incorporated administrative agency new energy, industry technology overall development mechanism (NEDO) industry technology practical use development business more in the 2003-2005 year and makes new application characteristics of polyphosphoric acid sodium a right widely and I commercialize the high "division polyphosphoric acid" of the effect particularly and apply it to an unregulated drug, cosmetics. I develop a product in the field of dentistry and oral care and sell it now.

I it in a receiving a prize career

Footnote

Outside link

This article is taken from the Japanese Wikipedia Re-Gen Thijs

This article is distributed by cc-by-sa or GFDL license in accordance with the provisions of Wikipedia.

Wikipedia and Tranpedia does not guarantee the accuracy of this document. See our disclaimer for more information.

In addition, Tranpedia is simply not responsible for any show is only by translating the writings of foreign licenses that are compatible with CC-BY-SA license information.

0 개의 댓글:

댓글 쓰기